Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial.

Tap WD, Gelderblom H, Palmerini E, Desai J, Bauer S, Blay JY, Alcindor T, Ganjoo K, Martín-Broto J, Ryan CW, Thomas DM, Peterfy C, Healey JH, van de Sande M, Gelhorn HL, Shuster DE, Wang Q, Yver A, Hsu HH, Lin PS, Tong-Starksen S, Stacchiotti S, Wagner AJ; ENLIVEN investigators.

Lancet. 2019 Aug 10;394(10197):478-487. doi: 10.1016/S0140-6736(19)30764-0. Epub 2019 Jun 19.

PMID:
31229240
2.

Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine.

Cortes J, Vahdat L, Blum JL, Twelves C, Campone M, Roché H, Bachelot T, Awada A, Paridaens R, Goncalves A, Shuster DE, Wanders J, Fang F, Gurnani R, Richmond E, Cole PE, Ashworth S, Allison MA.

J Clin Oncol. 2010 Sep 1;28(25):3922-8. doi: 10.1200/JCO.2009.25.8467. Epub 2010 Aug 2.

PMID:
20679609
3.

The odyssey of marine pharmaceuticals: a current pipeline perspective.

Mayer AM, Glaser KB, Cuevas C, Jacobs RS, Kem W, Little RD, McIntosh JM, Newman DJ, Potts BC, Shuster DE.

Trends Pharmacol Sci. 2010 Jun;31(6):255-65. doi: 10.1016/j.tips.2010.02.005. Epub 2010 Apr 2. Review.

PMID:
20363514
4.

A phase I study of eribulin mesylate (E7389), a mechanistically novel inhibitor of microtubule dynamics, in patients with advanced solid malignancies.

Goel S, Mita AC, Mita M, Rowinsky EK, Chu QS, Wong N, Desjardins C, Fang F, Jansen M, Shuster DE, Mani S, Takimoto CH.

Clin Cancer Res. 2009 Jun 15;15(12):4207-12. doi: 10.1158/1078-0432.CCR-08-2429. Epub 2009 Jun 9.

5.

Phase I study of eribulin mesylate administered once every 21 days in patients with advanced solid tumors.

Tan AR, Rubin EH, Walton DC, Shuster DE, Wong YN, Fang F, Ashworth S, Rosen LS.

Clin Cancer Res. 2009 Jun 15;15(12):4213-9. doi: 10.1158/1078-0432.CCR-09-0360. Epub 2009 Jun 9.

6.

Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.

Vahdat LT, Pruitt B, Fabian CJ, Rivera RR, Smith DA, Tan-Chiu E, Wright J, Tan AR, Dacosta NA, Chuang E, Smith J, O'Shaughnessy J, Shuster DE, Meneses NL, Chandrawansa K, Fang F, Cole PE, Ashworth S, Blum JL.

J Clin Oncol. 2009 Jun 20;27(18):2954-61. doi: 10.1200/JCO.2008.17.7618. Epub 2009 Apr 6.

PMID:
19349550
7.
8.

Effect of recombinant bovine interleukin-1 beta in normal calves and in calves infected with bovine herpesvirus type 1.

Van Kessel AG, Godson DL, Baca-Estrada ME, Morsey MA, Hughes HP, Harland R, Shuster DE, Daley MJ, Babiuk LA.

J Interferon Cytokine Res. 1996 Nov;16(11):881-90.

PMID:
8938563
10.
11.

Regulation of bovine acute phase responses by recombinant interleukin-1 beta.

Godson DL, Baca-Estrada ME, Van Kessel AG, Hughes HP, Morsy MA, Van Donkersgoed J, Harland RJ, Shuster DE, Daley MJ, Babiuk LA.

Can J Vet Res. 1995 Oct;59(4):249-55.

12.

Neutrophilia in mice that lack the murine IL-8 receptor homolog.

Shuster DE, Kehrli ME Jr, Ackermann MR.

Science. 1995 Sep 15;269(5230):1590-1. No abstract available.

PMID:
7667641
13.

Effect of recombinant bovine interleukin-1 beta on viral/bacterial pneumonia in cattle.

Baca-Estrada ME, Godson DL, Hughes HP, Van Donkersgoed J, Van Kessel A, Harland R, Shuster DE, Daley M, Babiuk LA.

J Interferon Cytokine Res. 1995 May;15(5):431-9.

PMID:
7648445
14.
15.

Factors affecting milk somatic cells and their role in health of the bovine mammary gland.

Kehrli ME Jr, Shuster DE.

J Dairy Sci. 1994 Feb;77(2):619-27. Review.

16.

Bovine L-selectin: a peripheral lymphocyte homing receptor.

Bosworth BT, Dowbenko D, Shuster DE, Harp JA.

Vet Immunol Immunopathol. 1993 Aug;37(3-4):201-15.

PMID:
7694420
17.

Clinical manifestations of leukocyte adhesion deficiency in cattle: 14 cases (1977-1991).

Gilbert RO, Rebhun WC, Kim CA, Kehrli ME Jr, Shuster DE, Ackermann MR.

J Am Vet Med Assoc. 1993 Feb 1;202(3):445-9.

PMID:
8095042
18.

Cytokine production during endotoxin-induced mastitis in lactating dairy cows.

Shuster DE, Kehrli ME Jr, Stevens MG.

Am J Vet Res. 1993 Jan;54(1):80-5.

PMID:
8427476
19.

Identification and prevalence of a genetic defect that causes leukocyte adhesion deficiency in Holstein cattle.

Shuster DE, Kehrli ME Jr, Ackermann MR, Gilbert RO.

Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9225-9.

20.

Bovine leukocyte adhesion deficiency. Beta 2 integrin deficiency in young Holstein cattle.

Kehrli ME Jr, Ackermann MR, Shuster DE, van der Maaten MJ, Schmalstieg FC, Anderson DC, Hughes BJ.

Am J Pathol. 1992 Jun;140(6):1489-92. No abstract available.

21.

Sequence of the bovine CD18-encoding cDNA: comparison with the human and murine glycoproteins.

Shuster DE, Bosworth BT, Kehrli ME Jr.

Gene. 1992 May 15;114(2):267-71.

PMID:
1351021
22.

Leukocyte adhesion deficiency among Holstein cattle.

Kehrli ME Jr, Shuster DE, Ackermann MR.

Cornell Vet. 1992 Apr;82(2):103-9. No abstract available.

23.
24.

Light microscopic and ultrastructural pathology of seminiferous tubules of rats given multiple doses of Pasteurella multocida group D protein toxin.

Ackermann MR, Tappe JP Jr, Thurston JR, Rimler RB, Shuster DE, Cheville NF.

Toxicol Pathol. 1992;20(1):103-11.

PMID:
1411123
26.

Suppression of milk production during endotoxin-induced mastitis.

Shuster DE, Harmon RJ, Jackson JA, Hemken RW.

J Dairy Sci. 1991 Nov;74(11):3763-74.

27.

Reduced lactational performance following intravenous endotoxin administration to dairy cows.

Shuster DE, Harmon RJ, Jackson JA, Hemken RW.

J Dairy Sci. 1991 Oct;74(10):3407-11.

28.

Endotoxin mastitis in cows milked four times daily.

Shuster DE, Harmon RJ, Jackson JA, Hemken RW.

J Dairy Sci. 1991 May;74(5):1527-38.

29.

Physiological responses to intramammary or intravenous treatment with endotoxin in lactating dairy cows.

Jackson JA, Shuster DE, Silvia WJ, Harmon RJ.

J Dairy Sci. 1990 Mar;73(3):627-32.

30.

Effects of premilking udder preparation on bacterial population, sediment, and iodine residue in milk.

Galton DM, Petersson LG, Merrill WG, Bandler DK, Shuster DE.

J Dairy Sci. 1984 Nov;67(11):2580-9.

Supplemental Content

Loading ...
Support Center